P, M., D, H., JA, S., & W, V. C. (2019). Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: Two case reports. BMC urology, 19(1), 124. https://doi.org/10.1186/s12894-019-0561-6
Chicago Style (17th ed.) CitationP, Minnee, Hessels D, Schalken JA, and Van Criekinge W. "Clinically Significant Prostate Cancer Diagnosed Using a Urinary Molecular Biomarker-based Risk Score: Two Case Reports." BMC Urology 19, no. 1 (2019): 124. https://doi.org/10.1186/s12894-019-0561-6.
MLA (9th ed.) CitationP, Minnee, et al. "Clinically Significant Prostate Cancer Diagnosed Using a Urinary Molecular Biomarker-based Risk Score: Two Case Reports." BMC Urology, vol. 19, no. 1, 2019, p. 124, https://doi.org/10.1186/s12894-019-0561-6.